nodes	percent_of_prediction	percent_of_DWPC	metapath
Cysteamine—NPY2R—epilepsy syndrome	0.432	0.656	CbGaD
Cysteamine—SST—epilepsy syndrome	0.227	0.344	CbGaD
Cysteamine—SST—vagus nerve—epilepsy syndrome	0.0124	0.183	CbGeAlD
Cysteamine—SST—autonomic nervous system—epilepsy syndrome	0.00858	0.127	CbGeAlD
Cysteamine—NPY2R—forebrain—epilepsy syndrome	0.00512	0.0756	CbGeAlD
Cysteamine—SST—ganglion—epilepsy syndrome	0.00476	0.0704	CbGeAlD
Cysteamine—NPY2R—telencephalon—epilepsy syndrome	0.00471	0.0696	CbGeAlD
Cysteamine—SST—hindbrain—epilepsy syndrome	0.00361	0.0534	CbGeAlD
Cysteamine—NPY2R—head—epilepsy syndrome	0.00293	0.0433	CbGeAlD
Cysteamine—NPY2R—nervous system—epilepsy syndrome	0.00278	0.0411	CbGeAlD
Cysteamine—NPY2R—central nervous system—epilepsy syndrome	0.00268	0.0395	CbGeAlD
Cysteamine—NPY2R—brain—epilepsy syndrome	0.00212	0.0314	CbGeAlD
Cysteamine—SST—brainstem—epilepsy syndrome	0.00207	0.0306	CbGeAlD
Cysteamine—SST—forebrain—epilepsy syndrome	0.002	0.0295	CbGeAlD
Cysteamine—SST—telencephalon—epilepsy syndrome	0.00184	0.0272	CbGeAlD
Cysteamine—SST—medulla oblongata—epilepsy syndrome	0.00144	0.0213	CbGeAlD
Cysteamine—SST—midbrain—epilepsy syndrome	0.00132	0.0195	CbGeAlD
Cysteamine—SST—spinal cord—epilepsy syndrome	0.00129	0.019	CbGeAlD
Cysteamine—SST—head—epilepsy syndrome	0.00114	0.0169	CbGeAlD
Cysteamine—SST—nervous system—epilepsy syndrome	0.00108	0.016	CbGeAlD
Cysteamine—SST—central nervous system—epilepsy syndrome	0.00104	0.0154	CbGeAlD
Cysteamine—SST—cerebellum—epilepsy syndrome	0.00102	0.0151	CbGeAlD
Cysteamine—SST—brain—epilepsy syndrome	0.000829	0.0123	CbGeAlD
Cysteamine—MPO—forebrain—epilepsy syndrome	0.000805	0.0119	CbGeAlD
Cysteamine—MPO—spinal cord—epilepsy syndrome	0.000519	0.00766	CbGeAlD
Cysteamine—MPO—head—epilepsy syndrome	0.000461	0.00681	CbGeAlD
Cysteamine—MPO—nervous system—epilepsy syndrome	0.000437	0.00646	CbGeAlD
Cysteamine—MPO—central nervous system—epilepsy syndrome	0.000421	0.00622	CbGeAlD
Cysteamine—MPO—brain—epilepsy syndrome	0.000334	0.00494	CbGeAlD
Cysteamine—Abdominal pain—Oxcarbazepine—epilepsy syndrome	7.44e-05	0.000502	CcSEcCtD
Cysteamine—Body temperature increased—Oxcarbazepine—epilepsy syndrome	7.44e-05	0.000502	CcSEcCtD
Cysteamine—Diarrhoea—Fosphenytoin—epilepsy syndrome	7.44e-05	0.000502	CcSEcCtD
Cysteamine—Vomiting—Propofol—epilepsy syndrome	7.42e-05	0.0005	CcSEcCtD
Cysteamine—Gastrointestinal pain—Carbamazepine—epilepsy syndrome	7.39e-05	0.000498	CcSEcCtD
Cysteamine—Rash—Propofol—epilepsy syndrome	7.35e-05	0.000496	CcSEcCtD
Cysteamine—Dermatitis—Propofol—epilepsy syndrome	7.35e-05	0.000496	CcSEcCtD
Cysteamine—Hypertension—Valproic Acid—epilepsy syndrome	7.34e-05	0.000495	CcSEcCtD
Cysteamine—Immune system disorder—Gabapentin—epilepsy syndrome	7.31e-05	0.000493	CcSEcCtD
Cysteamine—Headache—Propofol—epilepsy syndrome	7.31e-05	0.000493	CcSEcCtD
Cysteamine—Hypersensitivity—Zonisamide—epilepsy syndrome	7.29e-05	0.000491	CcSEcCtD
Cysteamine—Vomiting—Midazolam—epilepsy syndrome	7.26e-05	0.000489	CcSEcCtD
Cysteamine—Diarrhoea—Vigabatrin—epilepsy syndrome	7.25e-05	0.000489	CcSEcCtD
Cysteamine—Asthenia—Felbamate—epilepsy syndrome	7.25e-05	0.000489	CcSEcCtD
Cysteamine—Tremor—Pregabalin—epilepsy syndrome	7.2e-05	0.000486	CcSEcCtD
Cysteamine—Feeling abnormal—Lamotrigine—epilepsy syndrome	7.2e-05	0.000485	CcSEcCtD
Cysteamine—Rash—Midazolam—epilepsy syndrome	7.2e-05	0.000485	CcSEcCtD
Cysteamine—Dizziness—Fosphenytoin—epilepsy syndrome	7.19e-05	0.000485	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—epilepsy syndrome	7.19e-05	0.000485	CcSEcCtD
Cysteamine—Dermatitis—Midazolam—epilepsy syndrome	7.19e-05	0.000485	CcSEcCtD
Cysteamine—Urticaria—Carbamazepine—epilepsy syndrome	7.18e-05	0.000484	CcSEcCtD
Cysteamine—Vomiting—Levetiracetam—epilepsy syndrome	7.17e-05	0.000483	CcSEcCtD
Cysteamine—Discomfort—Valproic Acid—epilepsy syndrome	7.15e-05	0.000482	CcSEcCtD
Cysteamine—Headache—Midazolam—epilepsy syndrome	7.15e-05	0.000482	CcSEcCtD
Cysteamine—Abdominal pain—Carbamazepine—epilepsy syndrome	7.14e-05	0.000482	CcSEcCtD
Cysteamine—Body temperature increased—Carbamazepine—epilepsy syndrome	7.14e-05	0.000482	CcSEcCtD
Cysteamine—Diarrhoea—Diazepam—epilepsy syndrome	7.14e-05	0.000482	CcSEcCtD
Cysteamine—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	7.14e-05	0.000482	CcSEcCtD
Cysteamine—Rash—Levetiracetam—epilepsy syndrome	7.11e-05	0.000479	CcSEcCtD
Cysteamine—Anaemia—Pregabalin—epilepsy syndrome	7.11e-05	0.000479	CcSEcCtD
Cysteamine—Dermatitis—Levetiracetam—epilepsy syndrome	7.1e-05	0.000479	CcSEcCtD
Cysteamine—Asthenia—Zonisamide—epilepsy syndrome	7.1e-05	0.000478	CcSEcCtD
Cysteamine—Mental disorder—Gabapentin—epilepsy syndrome	7.09e-05	0.000478	CcSEcCtD
Cysteamine—Agitation—Pregabalin—epilepsy syndrome	7.06e-05	0.000476	CcSEcCtD
Cysteamine—Headache—Levetiracetam—epilepsy syndrome	7.06e-05	0.000476	CcSEcCtD
Cysteamine—Erythema—Gabapentin—epilepsy syndrome	7.05e-05	0.000475	CcSEcCtD
Cysteamine—Malnutrition—Gabapentin—epilepsy syndrome	7.05e-05	0.000475	CcSEcCtD
Cysteamine—Hypersensitivity—Clonazepam—epilepsy syndrome	7.02e-05	0.000474	CcSEcCtD
Cysteamine—Dizziness—Vigabatrin—epilepsy syndrome	7.01e-05	0.000473	CcSEcCtD
Cysteamine—Confusional state—Valproic Acid—epilepsy syndrome	7e-05	0.000472	CcSEcCtD
Cysteamine—Hypersensitivity—Phenytoin—epilepsy syndrome	6.97e-05	0.00047	CcSEcCtD
Cysteamine—Anaphylactic shock—Valproic Acid—epilepsy syndrome	6.94e-05	0.000468	CcSEcCtD
Cysteamine—Urticaria—Lamotrigine—epilepsy syndrome	6.94e-05	0.000468	CcSEcCtD
Cysteamine—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	6.94e-05	0.000468	CcSEcCtD
Cysteamine—Nausea—Propofol—epilepsy syndrome	6.93e-05	0.000467	CcSEcCtD
Cysteamine—Tension—Gabapentin—epilepsy syndrome	6.92e-05	0.000466	CcSEcCtD
Cysteamine—Vomiting—Fosphenytoin—epilepsy syndrome	6.92e-05	0.000466	CcSEcCtD
Cysteamine—Diarrhoea—Felbamate—epilepsy syndrome	6.91e-05	0.000466	CcSEcCtD
Cysteamine—Body temperature increased—Lamotrigine—epilepsy syndrome	6.9e-05	0.000466	CcSEcCtD
Cysteamine—Abdominal pain—Lamotrigine—epilepsy syndrome	6.9e-05	0.000466	CcSEcCtD
Cysteamine—Dizziness—Diazepam—epilepsy syndrome	6.9e-05	0.000465	CcSEcCtD
Cysteamine—Leukopenia—Pregabalin—epilepsy syndrome	6.88e-05	0.000464	CcSEcCtD
Cysteamine—Rash—Fosphenytoin—epilepsy syndrome	6.86e-05	0.000462	CcSEcCtD
Cysteamine—Dermatitis—Fosphenytoin—epilepsy syndrome	6.85e-05	0.000462	CcSEcCtD
Cysteamine—Nervousness—Gabapentin—epilepsy syndrome	6.85e-05	0.000462	CcSEcCtD
Cysteamine—Asthenia—Clonazepam—epilepsy syndrome	6.84e-05	0.000461	CcSEcCtD
Cysteamine—Headache—Fosphenytoin—epilepsy syndrome	6.81e-05	0.00046	CcSEcCtD
Cysteamine—Nervous system disorder—Valproic Acid—epilepsy syndrome	6.81e-05	0.000459	CcSEcCtD
Cysteamine—Asthenia—Phenytoin—epilepsy syndrome	6.79e-05	0.000458	CcSEcCtD
Cysteamine—Nausea—Midazolam—epilepsy syndrome	6.78e-05	0.000457	CcSEcCtD
Cysteamine—Hallucination—Topiramate—epilepsy syndrome	6.78e-05	0.000457	CcSEcCtD
Cysteamine—Diarrhoea—Zonisamide—epilepsy syndrome	6.77e-05	0.000456	CcSEcCtD
Cysteamine—Asthenia—Oxcarbazepine—epilepsy syndrome	6.76e-05	0.000456	CcSEcCtD
Cysteamine—Vomiting—Vigabatrin—epilepsy syndrome	6.74e-05	0.000455	CcSEcCtD
Cysteamine—Skin disorder—Valproic Acid—epilepsy syndrome	6.74e-05	0.000455	CcSEcCtD
Cysteamine—Urinary tract disorder—Topiramate—epilepsy syndrome	6.73e-05	0.000454	CcSEcCtD
Cysteamine—Connective tissue disorder—Topiramate—epilepsy syndrome	6.69e-05	0.000451	CcSEcCtD
Cysteamine—Nausea—Levetiracetam—epilepsy syndrome	6.69e-05	0.000451	CcSEcCtD
Cysteamine—Rash—Vigabatrin—epilepsy syndrome	6.69e-05	0.000451	CcSEcCtD
Cysteamine—Dizziness—Felbamate—epilepsy syndrome	6.68e-05	0.000451	CcSEcCtD
Cysteamine—Dermatitis—Vigabatrin—epilepsy syndrome	6.68e-05	0.00045	CcSEcCtD
Cysteamine—Urethral disorder—Topiramate—epilepsy syndrome	6.68e-05	0.00045	CcSEcCtD
Cysteamine—Convulsion—Pregabalin—epilepsy syndrome	6.66e-05	0.000449	CcSEcCtD
Cysteamine—Hypersensitivity—Carbamazepine—epilepsy syndrome	6.66e-05	0.000449	CcSEcCtD
Cysteamine—Headache—Vigabatrin—epilepsy syndrome	6.64e-05	0.000448	CcSEcCtD
Cysteamine—Hypertension—Pregabalin—epilepsy syndrome	6.64e-05	0.000448	CcSEcCtD
Cysteamine—Vomiting—Diazepam—epilepsy syndrome	6.64e-05	0.000448	CcSEcCtD
Cysteamine—Anorexia—Valproic Acid—epilepsy syndrome	6.62e-05	0.000446	CcSEcCtD
Cysteamine—Tremor—Gabapentin—epilepsy syndrome	6.6e-05	0.000445	CcSEcCtD
Cysteamine—Rash—Diazepam—epilepsy syndrome	6.58e-05	0.000444	CcSEcCtD
Cysteamine—Dermatitis—Diazepam—epilepsy syndrome	6.58e-05	0.000443	CcSEcCtD
Cysteamine—Dizziness—Zonisamide—epilepsy syndrome	6.54e-05	0.000441	CcSEcCtD
Cysteamine—Headache—Diazepam—epilepsy syndrome	6.54e-05	0.000441	CcSEcCtD
Cysteamine—Diarrhoea—Clonazepam—epilepsy syndrome	6.52e-05	0.00044	CcSEcCtD
Cysteamine—Anaemia—Gabapentin—epilepsy syndrome	6.52e-05	0.000439	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	6.5e-05	0.000438	CcSEcCtD
Cysteamine—Asthenia—Carbamazepine—epilepsy syndrome	6.48e-05	0.000437	CcSEcCtD
Cysteamine—Agitation—Gabapentin—epilepsy syndrome	6.48e-05	0.000437	CcSEcCtD
Cysteamine—Diarrhoea—Phenytoin—epilepsy syndrome	6.48e-05	0.000437	CcSEcCtD
Cysteamine—Discomfort—Pregabalin—epilepsy syndrome	6.47e-05	0.000436	CcSEcCtD
Cysteamine—Nausea—Fosphenytoin—epilepsy syndrome	6.46e-05	0.000436	CcSEcCtD
Cysteamine—Diarrhoea—Oxcarbazepine—epilepsy syndrome	6.44e-05	0.000434	CcSEcCtD
Cysteamine—Hypersensitivity—Lamotrigine—epilepsy syndrome	6.43e-05	0.000434	CcSEcCtD
Cysteamine—Vomiting—Felbamate—epilepsy syndrome	6.42e-05	0.000433	CcSEcCtD
Cysteamine—Rash—Felbamate—epilepsy syndrome	6.37e-05	0.00043	CcSEcCtD
Cysteamine—Dermatitis—Felbamate—epilepsy syndrome	6.36e-05	0.000429	CcSEcCtD
Cysteamine—Headache—Felbamate—epilepsy syndrome	6.33e-05	0.000427	CcSEcCtD
Cysteamine—Confusional state—Pregabalin—epilepsy syndrome	6.33e-05	0.000427	CcSEcCtD
Cysteamine—Leukopenia—Gabapentin—epilepsy syndrome	6.31e-05	0.000426	CcSEcCtD
Cysteamine—Dizziness—Clonazepam—epilepsy syndrome	6.3e-05	0.000425	CcSEcCtD
Cysteamine—Nausea—Vigabatrin—epilepsy syndrome	6.3e-05	0.000425	CcSEcCtD
Cysteamine—Vomiting—Zonisamide—epilepsy syndrome	6.29e-05	0.000424	CcSEcCtD
Cysteamine—Anaphylactic shock—Pregabalin—epilepsy syndrome	6.27e-05	0.000423	CcSEcCtD
Cysteamine—Asthenia—Lamotrigine—epilepsy syndrome	6.27e-05	0.000423	CcSEcCtD
Cysteamine—Dizziness—Phenytoin—epilepsy syndrome	6.26e-05	0.000422	CcSEcCtD
Cysteamine—Rash—Zonisamide—epilepsy syndrome	6.24e-05	0.00042	CcSEcCtD
Cysteamine—Dermatitis—Zonisamide—epilepsy syndrome	6.23e-05	0.00042	CcSEcCtD
Cysteamine—Dizziness—Oxcarbazepine—epilepsy syndrome	6.23e-05	0.00042	CcSEcCtD
Cysteamine—Nausea—Diazepam—epilepsy syndrome	6.2e-05	0.000418	CcSEcCtD
Cysteamine—Headache—Zonisamide—epilepsy syndrome	6.2e-05	0.000418	CcSEcCtD
Cysteamine—Diarrhoea—Carbamazepine—epilepsy syndrome	6.18e-05	0.000417	CcSEcCtD
Cysteamine—Somnolence—Valproic Acid—epilepsy syndrome	6.17e-05	0.000416	CcSEcCtD
Cysteamine—Immune system disorder—Topiramate—epilepsy syndrome	6.15e-05	0.000415	CcSEcCtD
Cysteamine—Nervous system disorder—Pregabalin—epilepsy syndrome	6.15e-05	0.000415	CcSEcCtD
Cysteamine—Dyspepsia—Valproic Acid—epilepsy syndrome	6.11e-05	0.000412	CcSEcCtD
Cysteamine—Convulsion—Gabapentin—epilepsy syndrome	6.11e-05	0.000412	CcSEcCtD
Cysteamine—Skin disorder—Pregabalin—epilepsy syndrome	6.09e-05	0.000411	CcSEcCtD
Cysteamine—Hypertension—Gabapentin—epilepsy syndrome	6.09e-05	0.00041	CcSEcCtD
Cysteamine—Vomiting—Clonazepam—epilepsy syndrome	6.06e-05	0.000409	CcSEcCtD
Cysteamine—Decreased appetite—Valproic Acid—epilepsy syndrome	6.03e-05	0.000407	CcSEcCtD
Cysteamine—Vomiting—Phenytoin—epilepsy syndrome	6.02e-05	0.000406	CcSEcCtD
Cysteamine—Rash—Clonazepam—epilepsy syndrome	6.01e-05	0.000405	CcSEcCtD
Cysteamine—Dermatitis—Clonazepam—epilepsy syndrome	6e-05	0.000405	CcSEcCtD
Cysteamine—Nausea—Felbamate—epilepsy syndrome	6e-05	0.000405	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	5.99e-05	0.000404	CcSEcCtD
Cysteamine—Vomiting—Oxcarbazepine—epilepsy syndrome	5.99e-05	0.000404	CcSEcCtD
Cysteamine—Fatigue—Valproic Acid—epilepsy syndrome	5.98e-05	0.000403	CcSEcCtD
Cysteamine—Anorexia—Pregabalin—epilepsy syndrome	5.98e-05	0.000403	CcSEcCtD
Cysteamine—Dizziness—Carbamazepine—epilepsy syndrome	5.98e-05	0.000403	CcSEcCtD
Cysteamine—Diarrhoea—Lamotrigine—epilepsy syndrome	5.98e-05	0.000403	CcSEcCtD
Cysteamine—Headache—Clonazepam—epilepsy syndrome	5.97e-05	0.000403	CcSEcCtD
Cysteamine—Rash—Phenytoin—epilepsy syndrome	5.97e-05	0.000403	CcSEcCtD
Cysteamine—Mental disorder—Topiramate—epilepsy syndrome	5.97e-05	0.000402	CcSEcCtD
Cysteamine—Dermatitis—Phenytoin—epilepsy syndrome	5.96e-05	0.000402	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	5.96e-05	0.000402	CcSEcCtD
Cysteamine—Rash—Oxcarbazepine—epilepsy syndrome	5.94e-05	0.0004	CcSEcCtD
Cysteamine—Constipation—Valproic Acid—epilepsy syndrome	5.93e-05	0.0004	CcSEcCtD
Cysteamine—Dermatitis—Oxcarbazepine—epilepsy syndrome	5.93e-05	0.0004	CcSEcCtD
Cysteamine—Headache—Phenytoin—epilepsy syndrome	5.93e-05	0.0004	CcSEcCtD
Cysteamine—Erythema—Topiramate—epilepsy syndrome	5.93e-05	0.0004	CcSEcCtD
Cysteamine—Malnutrition—Topiramate—epilepsy syndrome	5.93e-05	0.0004	CcSEcCtD
Cysteamine—Discomfort—Gabapentin—epilepsy syndrome	5.93e-05	0.0004	CcSEcCtD
Cysteamine—Headache—Oxcarbazepine—epilepsy syndrome	5.9e-05	0.000398	CcSEcCtD
Cysteamine—Nausea—Zonisamide—epilepsy syndrome	5.87e-05	0.000396	CcSEcCtD
Cysteamine—Tension—Topiramate—epilepsy syndrome	5.82e-05	0.000392	CcSEcCtD
Cysteamine—Confusional state—Gabapentin—epilepsy syndrome	5.8e-05	0.000391	CcSEcCtD
Cysteamine—Dizziness—Lamotrigine—epilepsy syndrome	5.78e-05	0.000389	CcSEcCtD
Cysteamine—Nervousness—Topiramate—epilepsy syndrome	5.76e-05	0.000388	CcSEcCtD
Cysteamine—Anaphylactic shock—Gabapentin—epilepsy syndrome	5.75e-05	0.000388	CcSEcCtD
Cysteamine—Vomiting—Carbamazepine—epilepsy syndrome	5.75e-05	0.000387	CcSEcCtD
Cysteamine—Feeling abnormal—Valproic Acid—epilepsy syndrome	5.72e-05	0.000386	CcSEcCtD
Cysteamine—Rash—Carbamazepine—epilepsy syndrome	5.7e-05	0.000384	CcSEcCtD
Cysteamine—Dermatitis—Carbamazepine—epilepsy syndrome	5.69e-05	0.000384	CcSEcCtD
Cysteamine—SST—Signaling Pathways—ST3GAL3—epilepsy syndrome	5.69e-05	0.000457	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—NPY—epilepsy syndrome	5.68e-05	0.000456	CbGpPWpGaD
Cysteamine—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	5.67e-05	0.000383	CcSEcCtD
Cysteamine—Nausea—Clonazepam—epilepsy syndrome	5.66e-05	0.000382	CcSEcCtD
Cysteamine—Headache—Carbamazepine—epilepsy syndrome	5.66e-05	0.000382	CcSEcCtD
Cysteamine—Nervous system disorder—Gabapentin—epilepsy syndrome	5.64e-05	0.00038	CcSEcCtD
Cysteamine—Nausea—Phenytoin—epilepsy syndrome	5.62e-05	0.000379	CcSEcCtD
Cysteamine—Nausea—Oxcarbazepine—epilepsy syndrome	5.59e-05	0.000377	CcSEcCtD
Cysteamine—Skin disorder—Gabapentin—epilepsy syndrome	5.59e-05	0.000377	CcSEcCtD
Cysteamine—Somnolence—Pregabalin—epilepsy syndrome	5.58e-05	0.000376	CcSEcCtD
Cysteamine—SST—Signaling Pathways—ARHGEF9—epilepsy syndrome	5.57e-05	0.000447	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—NPY2R—epilepsy syndrome	5.57e-05	0.000447	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—SSTR1—epilepsy syndrome	5.57e-05	0.000447	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—SSTR3—epilepsy syndrome	5.57e-05	0.000447	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CCR8—epilepsy syndrome	5.57e-05	0.000447	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CCR9—epilepsy syndrome	5.57e-05	0.000447	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—ADRA2A—epilepsy syndrome	5.57e-05	0.000447	CbGpPWpGaD
Cysteamine—Tremor—Topiramate—epilepsy syndrome	5.56e-05	0.000375	CcSEcCtD
Cysteamine—Vomiting—Lamotrigine—epilepsy syndrome	5.55e-05	0.000374	CcSEcCtD
Cysteamine—Urticaria—Valproic Acid—epilepsy syndrome	5.51e-05	0.000372	CcSEcCtD
Cysteamine—Rash—Lamotrigine—epilepsy syndrome	5.51e-05	0.000371	CcSEcCtD
Cysteamine—Dermatitis—Lamotrigine—epilepsy syndrome	5.5e-05	0.000371	CcSEcCtD
Cysteamine—Abdominal pain—Valproic Acid—epilepsy syndrome	5.49e-05	0.00037	CcSEcCtD
Cysteamine—Body temperature increased—Valproic Acid—epilepsy syndrome	5.49e-05	0.00037	CcSEcCtD
Cysteamine—Anorexia—Gabapentin—epilepsy syndrome	5.48e-05	0.00037	CcSEcCtD
Cysteamine—Anaemia—Topiramate—epilepsy syndrome	5.48e-05	0.00037	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—CXCL2—epilepsy syndrome	5.48e-05	0.00044	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—CRH—epilepsy syndrome	5.48e-05	0.00044	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—CCL3—epilepsy syndrome	5.48e-05	0.00044	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—OXT—epilepsy syndrome	5.48e-05	0.00044	CbGpPWpGaD
Cysteamine—Headache—Lamotrigine—epilepsy syndrome	5.47e-05	0.000369	CcSEcCtD
Cysteamine—SST—Signaling Pathways—GRM3—epilepsy syndrome	5.46e-05	0.000439	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—GRM4—epilepsy syndrome	5.46e-05	0.000439	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—CCR2—epilepsy syndrome	5.45e-05	0.000438	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—SST—epilepsy syndrome	5.45e-05	0.000438	CbGpPWpGaD
Cysteamine—Decreased appetite—Pregabalin—epilepsy syndrome	5.45e-05	0.000368	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—ST3GAL3—epilepsy syndrome	5.45e-05	0.000438	CbGpPWpGaD
Cysteamine—Agitation—Topiramate—epilepsy syndrome	5.45e-05	0.000368	CcSEcCtD
Cysteamine—MPO—Selenium Micronutrient Network—IL1B—epilepsy syndrome	5.43e-05	0.000436	CbGpPWpGaD
Cysteamine—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	5.42e-05	0.000365	CcSEcCtD
Cysteamine—Fatigue—Pregabalin—epilepsy syndrome	5.41e-05	0.000365	CcSEcCtD
Cysteamine—Nausea—Carbamazepine—epilepsy syndrome	5.37e-05	0.000362	CcSEcCtD
Cysteamine—Constipation—Pregabalin—epilepsy syndrome	5.37e-05	0.000362	CcSEcCtD
Cysteamine—SST—Signaling Pathways—DUSP4—epilepsy syndrome	5.36e-05	0.000431	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—SSTR2—epilepsy syndrome	5.36e-05	0.000431	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—BDKRB2—epilepsy syndrome	5.35e-05	0.00043	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—CXCL12—epilepsy syndrome	5.35e-05	0.00043	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CCR9—epilepsy syndrome	5.34e-05	0.000429	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—SSTR1—epilepsy syndrome	5.34e-05	0.000429	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CCR8—epilepsy syndrome	5.34e-05	0.000429	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—ARHGEF9—epilepsy syndrome	5.34e-05	0.000429	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—ADRA2A—epilepsy syndrome	5.34e-05	0.000429	CbGpPWpGaD
Cysteamine—Leukopenia—Topiramate—epilepsy syndrome	5.31e-05	0.000358	CcSEcCtD
Cysteamine—SST—GPCR downstream signaling—CNR1—epilepsy syndrome	5.25e-05	0.000422	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—GRM3—epilepsy syndrome	5.24e-05	0.000421	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—GRM4—epilepsy syndrome	5.24e-05	0.000421	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—PLCB1—epilepsy syndrome	5.23e-05	0.00042	CbGpPWpGaD
Cysteamine—Nausea—Lamotrigine—epilepsy syndrome	5.19e-05	0.00035	CcSEcCtD
Cysteamine—SST—Signaling Pathways—GRM8—epilepsy syndrome	5.18e-05	0.000416	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PGF—epilepsy syndrome	5.18e-05	0.000416	CbGpPWpGaD
Cysteamine—Feeling abnormal—Pregabalin—epilepsy syndrome	5.17e-05	0.000349	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—CCR2—epilepsy syndrome	5.17e-05	0.000415	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—DUSP4—epilepsy syndrome	5.14e-05	0.000413	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—SSTR2—epilepsy syndrome	5.14e-05	0.000413	CbGpPWpGaD
Cysteamine—Convulsion—Topiramate—epilepsy syndrome	5.14e-05	0.000347	CcSEcCtD
Cysteamine—Gastrointestinal pain—Pregabalin—epilepsy syndrome	5.13e-05	0.000346	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—CXCL12—epilepsy syndrome	5.13e-05	0.000412	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—BDKRB2—epilepsy syndrome	5.13e-05	0.000412	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—HTR7—epilepsy syndrome	5.12e-05	0.000411	CbGpPWpGaD
Cysteamine—Hypertension—Topiramate—epilepsy syndrome	5.12e-05	0.000345	CcSEcCtD
Cysteamine—Somnolence—Gabapentin—epilepsy syndrome	5.11e-05	0.000345	CcSEcCtD
Cysteamine—Hypersensitivity—Valproic Acid—epilepsy syndrome	5.11e-05	0.000345	CcSEcCtD
Cysteamine—SST—GPCR ligand binding—POMC—epilepsy syndrome	5.07e-05	0.000407	CbGpPWpGaD
Cysteamine—Dyspepsia—Gabapentin—epilepsy syndrome	5.06e-05	0.000342	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—ADRA2A—epilepsy syndrome	5.06e-05	0.000406	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—CNR1—epilepsy syndrome	5.03e-05	0.000404	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—PLCB1—epilepsy syndrome	5.02e-05	0.000403	CbGpPWpGaD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	5.01e-05	0.000338	CcSEcCtD
Cysteamine—Decreased appetite—Gabapentin—epilepsy syndrome	5e-05	0.000337	CcSEcCtD
Cysteamine—Discomfort—Topiramate—epilepsy syndrome	4.99e-05	0.000336	CcSEcCtD
Cysteamine—Urticaria—Pregabalin—epilepsy syndrome	4.98e-05	0.000336	CcSEcCtD
Cysteamine—Asthenia—Valproic Acid—epilepsy syndrome	4.98e-05	0.000336	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	4.97e-05	0.000335	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—PGF—epilepsy syndrome	4.97e-05	0.000399	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—GRM8—epilepsy syndrome	4.97e-05	0.000399	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—CCL2—epilepsy syndrome	4.96e-05	0.000398	CbGpPWpGaD
Cysteamine—Fatigue—Gabapentin—epilepsy syndrome	4.96e-05	0.000334	CcSEcCtD
Cysteamine—Abdominal pain—Pregabalin—epilepsy syndrome	4.96e-05	0.000334	CcSEcCtD
Cysteamine—Body temperature increased—Pregabalin—epilepsy syndrome	4.96e-05	0.000334	CcSEcCtD
Cysteamine—MPO—Folate Metabolism—TNF—epilepsy syndrome	4.96e-05	0.000398	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—CCR2—epilepsy syndrome	4.95e-05	0.000398	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—SST—epilepsy syndrome	4.95e-05	0.000398	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—OPRD1—epilepsy syndrome	4.94e-05	0.000397	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—GNAO1—epilepsy syndrome	4.94e-05	0.000397	CbGpPWpGaD
Cysteamine—Constipation—Gabapentin—epilepsy syndrome	4.92e-05	0.000332	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—HTR7—epilepsy syndrome	4.91e-05	0.000394	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—AKT3—epilepsy syndrome	4.88e-05	0.000392	CbGpPWpGaD
Cysteamine—Confusional state—Topiramate—epilepsy syndrome	4.88e-05	0.000329	CcSEcCtD
Cysteamine—NPY2R—GPCR ligand binding—POMC—epilepsy syndrome	4.86e-05	0.00039	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—CXCL12—epilepsy syndrome	4.86e-05	0.00039	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—BDKRB2—epilepsy syndrome	4.86e-05	0.00039	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—ADRA2A—epilepsy syndrome	4.85e-05	0.000389	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—CNR1—epilepsy syndrome	4.77e-05	0.000383	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—CCL2—epilepsy syndrome	4.76e-05	0.000382	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—PLCB1—epilepsy syndrome	4.75e-05	0.000382	CbGpPWpGaD
Cysteamine—Diarrhoea—Valproic Acid—epilepsy syndrome	4.75e-05	0.00032	CcSEcCtD
Cysteamine—Nervous system disorder—Topiramate—epilepsy syndrome	4.75e-05	0.00032	CcSEcCtD
Cysteamine—Feeling abnormal—Gabapentin—epilepsy syndrome	4.74e-05	0.00032	CcSEcCtD
Cysteamine—SST—Signaling Pathways—CHRM1—epilepsy syndrome	4.74e-05	0.00038	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CCR7—epilepsy syndrome	4.74e-05	0.00038	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PDYN—epilepsy syndrome	4.74e-05	0.00038	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—OPRD1—epilepsy syndrome	4.74e-05	0.00038	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—GRM1—epilepsy syndrome	4.74e-05	0.00038	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—GNAO1—epilepsy syndrome	4.74e-05	0.00038	CbGpPWpGaD
Cysteamine—Gastrointestinal pain—Gabapentin—epilepsy syndrome	4.7e-05	0.000317	CcSEcCtD
Cysteamine—Skin disorder—Topiramate—epilepsy syndrome	4.7e-05	0.000317	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—AKT3—epilepsy syndrome	4.68e-05	0.000376	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—CXCL12—epilepsy syndrome	4.66e-05	0.000374	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—BDKRB2—epilepsy syndrome	4.66e-05	0.000374	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—HTR7—epilepsy syndrome	4.65e-05	0.000374	CbGpPWpGaD
Cysteamine—Hypersensitivity—Pregabalin—epilepsy syndrome	4.62e-05	0.000312	CcSEcCtD
Cysteamine—Anorexia—Topiramate—epilepsy syndrome	4.61e-05	0.000311	CcSEcCtD
Cysteamine—Dizziness—Valproic Acid—epilepsy syndrome	4.59e-05	0.000309	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—CNR1—epilepsy syndrome	4.57e-05	0.000367	CbGpPWpGaD
Cysteamine—Urticaria—Gabapentin—epilepsy syndrome	4.57e-05	0.000308	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—PLCB1—epilepsy syndrome	4.55e-05	0.000366	CbGpPWpGaD
Cysteamine—Body temperature increased—Gabapentin—epilepsy syndrome	4.55e-05	0.000307	CcSEcCtD
Cysteamine—Abdominal pain—Gabapentin—epilepsy syndrome	4.55e-05	0.000307	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—GRM1—epilepsy syndrome	4.54e-05	0.000365	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PDYN—epilepsy syndrome	4.54e-05	0.000365	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CCR7—epilepsy syndrome	4.54e-05	0.000365	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CHRM1—epilepsy syndrome	4.54e-05	0.000365	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—HBEGF—epilepsy syndrome	4.52e-05	0.000363	CbGpPWpGaD
Cysteamine—Asthenia—Pregabalin—epilepsy syndrome	4.5e-05	0.000304	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—HTR7—epilepsy syndrome	4.46e-05	0.000358	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—CDC42—epilepsy syndrome	4.45e-05	0.000358	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—GFAP—epilepsy syndrome	4.45e-05	0.000358	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—GAL—epilepsy syndrome	4.45e-05	0.000358	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—AKT3—epilepsy syndrome	4.43e-05	0.000356	CbGpPWpGaD
Cysteamine—Vomiting—Valproic Acid—epilepsy syndrome	4.41e-05	0.000298	CcSEcCtD
Cysteamine—SST—Signaling Pathways—CHRM3—epilepsy syndrome	4.4e-05	0.000354	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—GRM5—epilepsy syndrome	4.4e-05	0.000354	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CASP2—epilepsy syndrome	4.4e-05	0.000354	CbGpPWpGaD
Cysteamine—Rash—Valproic Acid—epilepsy syndrome	4.38e-05	0.000295	CcSEcCtD
Cysteamine—Dermatitis—Valproic Acid—epilepsy syndrome	4.37e-05	0.000295	CcSEcCtD
Cysteamine—Headache—Valproic Acid—epilepsy syndrome	4.35e-05	0.000293	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—HBEGF—epilepsy syndrome	4.33e-05	0.000348	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—AVP—epilepsy syndrome	4.31e-05	0.000346	CbGpPWpGaD
Cysteamine—Somnolence—Topiramate—epilepsy syndrome	4.3e-05	0.00029	CcSEcCtD
Cysteamine—Diarrhoea—Pregabalin—epilepsy syndrome	4.29e-05	0.000289	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—CDC42—epilepsy syndrome	4.27e-05	0.000343	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—GAL—epilepsy syndrome	4.27e-05	0.000343	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—GFAP—epilepsy syndrome	4.27e-05	0.000343	CbGpPWpGaD
Cysteamine—Dyspepsia—Topiramate—epilepsy syndrome	4.26e-05	0.000287	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—AKT3—epilepsy syndrome	4.25e-05	0.000341	CbGpPWpGaD
Cysteamine—Hypersensitivity—Gabapentin—epilepsy syndrome	4.24e-05	0.000286	CcSEcCtD
Cysteamine—SST—Signaling Pathways—CX3CR1—epilepsy syndrome	4.22e-05	0.000339	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—GRM5—epilepsy syndrome	4.22e-05	0.000339	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CHRM3—epilepsy syndrome	4.22e-05	0.000339	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CASP2—epilepsy syndrome	4.22e-05	0.000339	CbGpPWpGaD
Cysteamine—Decreased appetite—Topiramate—epilepsy syndrome	4.21e-05	0.000284	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Topiramate—epilepsy syndrome	4.18e-05	0.000282	CcSEcCtD
Cysteamine—Fatigue—Topiramate—epilepsy syndrome	4.17e-05	0.000281	CcSEcCtD
Cysteamine—Dizziness—Pregabalin—epilepsy syndrome	4.15e-05	0.00028	CcSEcCtD
Cysteamine—SST—Signaling Pathways—CHRM2—epilepsy syndrome	4.14e-05	0.000333	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—BDKRB1—epilepsy syndrome	4.14e-05	0.000333	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CX3CL1—epilepsy syndrome	4.14e-05	0.000333	CbGpPWpGaD
Cysteamine—Constipation—Topiramate—epilepsy syndrome	4.14e-05	0.000279	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—AVP—epilepsy syndrome	4.13e-05	0.000332	CbGpPWpGaD
Cysteamine—Asthenia—Gabapentin—epilepsy syndrome	4.13e-05	0.000278	CcSEcCtD
Cysteamine—Nausea—Valproic Acid—epilepsy syndrome	4.12e-05	0.000278	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—CX3CR1—epilepsy syndrome	4.05e-05	0.000325	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—CDC42—epilepsy syndrome	4.04e-05	0.000325	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—GABBR1—epilepsy syndrome	4.03e-05	0.000323	CbGpPWpGaD
Cysteamine—Vomiting—Pregabalin—epilepsy syndrome	3.99e-05	0.000269	CcSEcCtD
Cysteamine—Feeling abnormal—Topiramate—epilepsy syndrome	3.99e-05	0.000269	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—BDKRB1—epilepsy syndrome	3.97e-05	0.000319	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CX3CL1—epilepsy syndrome	3.97e-05	0.000319	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CHRM2—epilepsy syndrome	3.97e-05	0.000319	CbGpPWpGaD
Cysteamine—Gastrointestinal pain—Topiramate—epilepsy syndrome	3.96e-05	0.000267	CcSEcCtD
Cysteamine—Rash—Pregabalin—epilepsy syndrome	3.96e-05	0.000267	CcSEcCtD
Cysteamine—Dermatitis—Pregabalin—epilepsy syndrome	3.95e-05	0.000267	CcSEcCtD
Cysteamine—MPO—Selenium Micronutrient Network—TNF—epilepsy syndrome	3.94e-05	0.000316	CbGpPWpGaD
Cysteamine—Diarrhoea—Gabapentin—epilepsy syndrome	3.94e-05	0.000265	CcSEcCtD
Cysteamine—Headache—Pregabalin—epilepsy syndrome	3.93e-05	0.000265	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—AVP—epilepsy syndrome	3.92e-05	0.000314	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—CDC42—epilepsy syndrome	3.88e-05	0.000311	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—GABBR1—epilepsy syndrome	3.86e-05	0.00031	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—HRH3—epilepsy syndrome	3.86e-05	0.00031	CbGpPWpGaD
Cysteamine—Urticaria—Topiramate—epilepsy syndrome	3.85e-05	0.000259	CcSEcCtD
Cysteamine—Abdominal pain—Topiramate—epilepsy syndrome	3.83e-05	0.000258	CcSEcCtD
Cysteamine—Body temperature increased—Topiramate—epilepsy syndrome	3.83e-05	0.000258	CcSEcCtD
Cysteamine—Dizziness—Gabapentin—epilepsy syndrome	3.8e-05	0.000257	CcSEcCtD
Cysteamine—SST—Signaling Pathways—OPRM1—epilepsy syndrome	3.8e-05	0.000305	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—AVP—epilepsy syndrome	3.75e-05	0.000302	CbGpPWpGaD
Cysteamine—Nausea—Pregabalin—epilepsy syndrome	3.73e-05	0.000251	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—HRH3—epilepsy syndrome	3.7e-05	0.000297	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—CCR5—epilepsy syndrome	3.67e-05	0.000294	CbGpPWpGaD
Cysteamine—Vomiting—Gabapentin—epilepsy syndrome	3.66e-05	0.000247	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—OPRM1—epilepsy syndrome	3.64e-05	0.000293	CbGpPWpGaD
Cysteamine—Rash—Gabapentin—epilepsy syndrome	3.63e-05	0.000245	CcSEcCtD
Cysteamine—Dermatitis—Gabapentin—epilepsy syndrome	3.62e-05	0.000244	CcSEcCtD
Cysteamine—Headache—Gabapentin—epilepsy syndrome	3.6e-05	0.000243	CcSEcCtD
Cysteamine—SST—Signaling Pathways—CCR3—epilepsy syndrome	3.59e-05	0.000288	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—HTR2A—epilepsy syndrome	3.59e-05	0.000288	CbGpPWpGaD
Cysteamine—Hypersensitivity—Topiramate—epilepsy syndrome	3.57e-05	0.00024	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—CCR5—epilepsy syndrome	3.52e-05	0.000282	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—NPY—epilepsy syndrome	3.5e-05	0.000281	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—ATP2A2—epilepsy syndrome	3.5e-05	0.000281	CbGpPWpGaD
Cysteamine—Asthenia—Topiramate—epilepsy syndrome	3.47e-05	0.000234	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—CCR3—epilepsy syndrome	3.44e-05	0.000276	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—HTR2A—epilepsy syndrome	3.44e-05	0.000276	CbGpPWpGaD
Cysteamine—Nausea—Gabapentin—epilepsy syndrome	3.42e-05	0.00023	CcSEcCtD
Cysteamine—SST—GPCR downstream signaling—AGT—epilepsy syndrome	3.4e-05	0.000273	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CCL3—epilepsy syndrome	3.37e-05	0.000271	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CXCL2—epilepsy syndrome	3.37e-05	0.000271	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—HSPB1—epilepsy syndrome	3.37e-05	0.000271	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—OXT—epilepsy syndrome	3.37e-05	0.000271	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CRH—epilepsy syndrome	3.37e-05	0.000271	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—NPY—epilepsy syndrome	3.35e-05	0.000269	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—ATP2A2—epilepsy syndrome	3.35e-05	0.000269	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—CCR5—epilepsy syndrome	3.33e-05	0.000267	CbGpPWpGaD
Cysteamine—Diarrhoea—Topiramate—epilepsy syndrome	3.31e-05	0.000223	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—AGT—epilepsy syndrome	3.26e-05	0.000262	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—HTR2A—epilepsy syndrome	3.26e-05	0.000262	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—OXT—epilepsy syndrome	3.24e-05	0.00026	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—HSPB1—epilepsy syndrome	3.24e-05	0.00026	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CCL3—epilepsy syndrome	3.24e-05	0.00026	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CRH—epilepsy syndrome	3.24e-05	0.00026	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CXCL2—epilepsy syndrome	3.24e-05	0.00026	CbGpPWpGaD
Cysteamine—Dizziness—Topiramate—epilepsy syndrome	3.2e-05	0.000216	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—CCR5—epilepsy syndrome	3.19e-05	0.000256	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—PRKCB—epilepsy syndrome	3.15e-05	0.000253	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PTK2B—epilepsy syndrome	3.14e-05	0.000252	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—TSC1—epilepsy syndrome	3.14e-05	0.000252	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—HTR2A—epilepsy syndrome	3.12e-05	0.000251	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—AGT—epilepsy syndrome	3.09e-05	0.000248	CbGpPWpGaD
Cysteamine—Vomiting—Topiramate—epilepsy syndrome	3.08e-05	0.000208	CcSEcCtD
Cysteamine—SST—Signaling Pathways—NTRK2—epilepsy syndrome	3.05e-05	0.000245	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CCR2—epilepsy syndrome	3.05e-05	0.000245	CbGpPWpGaD
Cysteamine—Rash—Topiramate—epilepsy syndrome	3.05e-05	0.000206	CcSEcCtD
Cysteamine—Dermatitis—Topiramate—epilepsy syndrome	3.05e-05	0.000206	CcSEcCtD
Cysteamine—Headache—Topiramate—epilepsy syndrome	3.03e-05	0.000204	CcSEcCtD
Cysteamine—SST—Signaling Pathways—DUSP6—epilepsy syndrome	3.03e-05	0.000243	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—PRKCB—epilepsy syndrome	3.02e-05	0.000242	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—TSC1—epilepsy syndrome	3.01e-05	0.000242	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PTK2B—epilepsy syndrome	3.01e-05	0.000242	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—ADRA2A—epilepsy syndrome	2.99e-05	0.00024	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PLAT—epilepsy syndrome	2.97e-05	0.000239	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—AGT—epilepsy syndrome	2.96e-05	0.000238	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—SST—epilepsy syndrome	2.93e-05	0.000235	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—NTRK2—epilepsy syndrome	2.93e-05	0.000235	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CCR2—epilepsy syndrome	2.93e-05	0.000235	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—DUSP6—epilepsy syndrome	2.9e-05	0.000233	CbGpPWpGaD
Cysteamine—Nausea—Topiramate—epilepsy syndrome	2.87e-05	0.000194	CcSEcCtD
Cysteamine—SST—Signaling Pathways—BDKRB2—epilepsy syndrome	2.87e-05	0.00023	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CXCL12—epilepsy syndrome	2.87e-05	0.00023	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—POMC—epilepsy syndrome	2.87e-05	0.00023	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—ADRA2A—epilepsy syndrome	2.86e-05	0.00023	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—PRKCB—epilepsy syndrome	2.86e-05	0.000229	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PLAT—epilepsy syndrome	2.85e-05	0.000229	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—IL6ST—epilepsy syndrome	2.85e-05	0.000229	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CNR1—epilepsy syndrome	2.82e-05	0.000226	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—JUNB—epilepsy syndrome	2.82e-05	0.000226	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PLCB1—epilepsy syndrome	2.81e-05	0.000225	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CXCL12—epilepsy syndrome	2.75e-05	0.000221	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—BDKRB2—epilepsy syndrome	2.75e-05	0.000221	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—HTR7—epilepsy syndrome	2.75e-05	0.000221	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—POMC—epilepsy syndrome	2.75e-05	0.000221	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—PRKCB—epilepsy syndrome	2.74e-05	0.00022	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—IL6ST—epilepsy syndrome	2.73e-05	0.000219	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—JUNB—epilepsy syndrome	2.7e-05	0.000217	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CNR1—epilepsy syndrome	2.7e-05	0.000217	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PLCB1—epilepsy syndrome	2.69e-05	0.000216	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—HBEGF—epilepsy syndrome	2.67e-05	0.000214	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—HTR7—epilepsy syndrome	2.63e-05	0.000212	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—AKT3—epilepsy syndrome	2.62e-05	0.00021	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—POMC—epilepsy syndrome	2.6e-05	0.000209	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—ADAM10—epilepsy syndrome	2.56e-05	0.000205	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—HBEGF—epilepsy syndrome	2.56e-05	0.000205	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—CCL2—epilepsy syndrome	2.55e-05	0.000204	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—AKT3—epilepsy syndrome	2.51e-05	0.000202	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—POMC—epilepsy syndrome	2.49e-05	0.0002	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—ADAM10—epilepsy syndrome	2.45e-05	0.000197	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—CCL2—epilepsy syndrome	2.44e-05	0.000196	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—S100B—epilepsy syndrome	2.42e-05	0.000194	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—SOCS3—epilepsy syndrome	2.4e-05	0.000192	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CDC42—epilepsy syndrome	2.39e-05	0.000192	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—S100B—epilepsy syndrome	2.32e-05	0.000186	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—AVP—epilepsy syndrome	2.31e-05	0.000186	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—SOCS3—epilepsy syndrome	2.3e-05	0.000184	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CDC42—epilepsy syndrome	2.29e-05	0.000184	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—AVP—epilepsy syndrome	2.22e-05	0.000178	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—HES1—epilepsy syndrome	2.19e-05	0.000176	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—FYN—epilepsy syndrome	2.13e-05	0.000171	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—H2AFX—epilepsy syndrome	2.12e-05	0.00017	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—MEF2C—epilepsy syndrome	2.12e-05	0.00017	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—HES1—epilepsy syndrome	2.1e-05	0.000168	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—YWHAZ—epilepsy syndrome	2.04e-05	0.000164	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—FYN—epilepsy syndrome	2.04e-05	0.000164	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—H2AFX—epilepsy syndrome	2.03e-05	0.000163	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—MEF2C—epilepsy syndrome	2.03e-05	0.000163	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—NGF—epilepsy syndrome	2.02e-05	0.000162	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CCR5—epilepsy syndrome	1.97e-05	0.000158	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—YWHAZ—epilepsy syndrome	1.96e-05	0.000157	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—NGF—epilepsy syndrome	1.94e-05	0.000156	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—HTR2A—epilepsy syndrome	1.92e-05	0.000155	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CCR5—epilepsy syndrome	1.89e-05	0.000151	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—HTR2A—epilepsy syndrome	1.85e-05	0.000148	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—TSC2—epilepsy syndrome	1.83e-05	0.000147	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—AGT—epilepsy syndrome	1.83e-05	0.000147	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—APOE—epilepsy syndrome	1.79e-05	0.000144	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—KDR—epilepsy syndrome	1.75e-05	0.000141	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—TSC2—epilepsy syndrome	1.75e-05	0.000141	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—AGT—epilepsy syndrome	1.75e-05	0.000141	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—APOE—epilepsy syndrome	1.72e-05	0.000138	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PRKCB—epilepsy syndrome	1.69e-05	0.000136	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—IL6ST—epilepsy syndrome	1.68e-05	0.000135	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—KDR—epilepsy syndrome	1.68e-05	0.000135	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PRKCB—epilepsy syndrome	1.62e-05	0.00013	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—IL6ST—epilepsy syndrome	1.61e-05	0.000129	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—POMC—epilepsy syndrome	1.54e-05	0.000123	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CCL2—epilepsy syndrome	1.5e-05	0.000121	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—POMC—epilepsy syndrome	1.47e-05	0.000118	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CCL2—epilepsy syndrome	1.44e-05	0.000116	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—FGF2—epilepsy syndrome	1.36e-05	0.000109	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—FGF2—epilepsy syndrome	1.3e-05	0.000105	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—RELA—epilepsy syndrome	1.26e-05	0.000101	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—MTOR—epilepsy syndrome	1.24e-05	9.94e-05	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—RELA—epilepsy syndrome	1.21e-05	9.72e-05	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—MTOR—epilepsy syndrome	1.19e-05	9.53e-05	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—AKT1—epilepsy syndrome	1.15e-05	9.23e-05	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CASP3—epilepsy syndrome	1.14e-05	9.14e-05	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—JUN—epilepsy syndrome	1.11e-05	8.88e-05	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—AKT1—epilepsy syndrome	1.1e-05	8.85e-05	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CASP3—epilepsy syndrome	1.09e-05	8.76e-05	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—MMP9—epilepsy syndrome	1.08e-05	8.64e-05	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—JUN—epilepsy syndrome	1.06e-05	8.51e-05	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—AKT1—epilepsy syndrome	1.04e-05	8.38e-05	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—MMP9—epilepsy syndrome	1.03e-05	8.28e-05	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—AKT1—epilepsy syndrome	1e-05	8.03e-05	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—SRC—epilepsy syndrome	9.92e-06	7.96e-05	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—VEGFA—epilepsy syndrome	9.66e-06	7.76e-05	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—SRC—epilepsy syndrome	9.51e-06	7.64e-05	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—VEGFA—epilepsy syndrome	9.26e-06	7.44e-05	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—AKT1—epilepsy syndrome	6.16e-06	4.95e-05	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—AKT1—epilepsy syndrome	5.91e-06	4.74e-05	CbGpPWpGaD
